---
title: "688488.SH (688488.SH) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/688488.SH/news.md"
symbol: "688488.SH"
name: "688488.SH"
parent: "https://longbridge.com/en/quote/688488.SH.md"
datetime: "2026-05-21T14:34:38.652Z"
locales:
  - [en](https://longbridge.com/en/quote/688488.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688488.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688488.SH/news.md)
---

# 688488.SH (688488.SH) — Related News

### [Aidea Pharma: Completed the acquisition of 22.23% minority shareholder equity in the controlling subsidiary](https://longbridge.com/en/news/283785455.md)
*2026-04-23T07:47:29.000Z*
> Aidea Pharma announced that the company has completed the acquisition of 22.23% minority shareholder equity in its contr

### [Healthcare Industry Daily (04.06): Breakthroughs in Pharmaceuticals](https://longbridge.com/en/news/281790238.md)
*2026-04-06T19:15:22.000Z*
> Aidea Pharma announced that its new anti-HIV drug ACC085 injection has been approved to conduct clinical trials. This dr

### [Aidea Pharma: In the field of anti-HIV, the investigational new drug ACC085 injection will commence clinical trials](https://longbridge.com/en/news/281743394.md)
*2026-04-06T08:48:03.000Z*
> Aidea Pharma announced that its wholly-owned subsidiary Luzhou Aidea Pharmaceutical Technology Co., Ltd. has received ap

### [Jiangsu's biopharmaceutical industry is thriving, and local pharmaceutical companies claim that Hong Kong helps with financing for going global](https://longbridge.com/en/news/281591008.md)
*2026-04-03T01:19:02.000Z*
> The biopharmaceutical industry in Jiangsu Province is thriving, especially in the Suzhou Biopharmaceutical Industry Park

### ["20cm" First Board Aidea Pharma: ACC017 tablets have entered Phase III clinical trials,](https://longbridge.com/en/news/281361334.md)
*2026-04-01T09:59:15.000Z*
> Aidea Pharma responded to investor inquiries on April 1, stating that it is advancing the stock issuance process and wil

### [688488, 20% limit up at the close! Innovative drugs, a big explosion!](https://longbridge.com/en/news/281342033.md)
*2026-04-01T09:53:03.000Z*
> On April 1st, major Asia-Pacific stock indices performed strongly, with the Nikkei 225 index rising by 5.24%, marking th

### [HIV innovative drugs continue to increase in volume, Aidea Pharma's losses will narrow in 2025, and cash flow will turn from negative to positive](https://longbridge.com/en/news/281052477.md)
*2026-03-30T15:52:16.000Z*
> Aidea Pharma released its annual report for 2025, expecting a net profit loss of 19.5323 million yuan, a year-on-year na

### [Aidea Pharma: Net profit loss of 19.5323 million yuan in 2025](https://longbridge.com/en/news/281024818.md)
*2026-03-30T13:00:04.000Z*
> Sina Finance reported on March 30th that Aidea Pharma announced that its operating revenue in 2025 will be 719 million y

### [The Chinese Preventive Medicine Association and Aidea Pharma signed a project cooperation agreement](https://longbridge.com/en/news/280859860.md)
*2026-03-28T02:25:53.000Z*
> According to Aidea Pharma, on March 25th, the Chinese Preventive Medicine Association and Aidea Pharma officially signed